calpeptin has been researched along with Pancreatic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, H; Manabe, T; Miyasaka, Y; Mizumoto, K; Nabae, T; Nakamura, M; Ohtsuka, T; Ohuchida, K; Okumura, T; Shimamoto, M; Torata, N; Yoshida, M; Zheng, B | 1 |
1 other study(ies) available for calpeptin and Pancreatic Neoplasms
| Article | Year |
|---|---|
Calpain inhibitor calpeptin suppresses pancreatic cancer by disrupting cancer-stromal interactions in a mouse xenograft model.
Topics: Animals; Calpain; Cell Communication; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dipeptides; Disease Models, Animal; Gene Expression; Humans; Mice; Pancreatic Neoplasms; Pancreatic Stellate Cells; RNA, Messenger; Stromal Cells; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |